Episode 4: Targeted therapies in cancer: From clinic to labs

Summary

Episode 4 in the ‘Better Testing, Better Treatment’ podcast series, focuses on the topic of implementing target therapies in cancer, from a European point of view. This podcast will see a pathologist and oncologist discussing the topic from their perspectives and express similarities and differences.

Our guests include Professor. Frederique Penault-Llorca, CEO of the Comprehensive Regional Cancer Institute Centre Jean PERRIN, Clermont-Ferrand, France and Deputy President, UNICANCER, and Professor Pascal Pujol, Head of Cancer Genetics department at the University Hospital of Montpellier, France and President of the French Society of Predictive and Personalized Medicine (SFMPP).

Don't miss out on episode 3 of the series, 'Targeted therapies in Gastric cancer: From clinic to labs' for a US perspective!

Other episodes in the series are available to listen now.

The Better Testing, Better Treatment Podcast
Listen to more episodes on Spotify and Apple Podcasts 
Share:

Sign up to our newsletter

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.